Nystatin and Systemic sclerosis (scleroderma) - a phase IV clinical study of FDA data

Summary:

Systemic sclerosis (scleroderma) is reported as a side effect among people who take Nystatin (nystatin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ativan, and have Idiopathic pulmonary fibrosis.

The phase IV clinical study analyzes which people have Systemic sclerosis (scleroderma) when taking Nystatin. It is created by eHealthMe based on reports of 33,189 people who have side effects when taking Nystatin from the FDA, and is updated regularly.

What is Nystatin?

Nystatin has active ingredients of nystatin. It is often used in thrush. eHealthMe is studying from 33,567 Nystatin users. Check the latest studies of Nystatin.

What is Systemic sclerosis (scleroderma)?

Systemic sclerosis (scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin) is found to be associated with 495 drugs and 857 conditions by eHealthMe. Check the latest studies of Systemic sclerosis (scleroderma).

On Jul, 19, 2026

33,189 people reported to have side effects when taking Nystatin.
Among them, 15 people (0.05%) have Systemic sclerosis (scleroderma).

Could Nystatin cause Systemic sclerosis (scleroderma)?

Among these 15 people:

How long have people been on Nystatin when they have Systemic sclerosis (scleroderma)? *

What is the gender of people who have Systemic sclerosis (scleroderma) when taking Nystatin? *

female: 53.33 %
male: 46.67 %

What is the age of people who have Systemic sclerosis (scleroderma) when taking Nystatin? *

What are other drugs people take besides Nystatin? *

What are other side effects people have besides Systemic sclerosis (scleroderma)? *

Chest Pain: 7 people, 46.67%
Cardiac Failure Congestive: 7 people, 46.67%
Nausea (feeling of having an urge to vomit): 7 people, 46.67%
Dyspnea (difficult or laboured breathing): 6 people, 40.00%
Hypokalemia (low potassium): 5 people, 33.33%
Anaemia (lack of blood): 5 people, 33.33%
Injury: 5 people, 33.33%
Headache (pain in head): 5 people, 33.33%
Stress And Anxiety: 5 people, 33.33%
Abdominal Pain: 4 people, 26.67%

What are the existing conditions these people have? *

Trismus (reduced opening of the jaws): 3 people, 20.00%
Multiple Myeloma (cancer of the plasma cells): 3 people, 20.00%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 3 people, 20.00%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 13.33%
Spinal Pain (pain in spine): 1 person, 6.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.67%
Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 1 person, 6.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 6.67%
High Blood Pressure: 1 person, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Nystatin and have Systemic sclerosis (scleroderma)?

- Check whether Systemic sclerosis (scleroderma) is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nystatin:

Nystatin (33,567 reports)

Browse all side effects of Nystatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Systemic sclerosis (scleroderma):

Systemic sclerosis (scleroderma) (495 drugs)

Browse all the conditions that are associated with Systemic sclerosis (scleroderma):

Systemic sclerosis (scleroderma) (857 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nystatin (the active ingredients of Nystatin) and Nystatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.